103 related articles for article (PubMed ID: 6447742)
21. Sensitization of human lymphocytes in vitro: genetic restriction of secondary T cell responses is dictated by the HLA-DR phenotype of antigen-presenting cells.
Ford DM; Hamblin A; Burger DR
J Immunol; 1982 May; 128(5):2170-6. PubMed ID: 6977584
[TBL] [Abstract][Full Text] [Related]
22. The role of HLA-DR and HLA-DQ products in T lymphocyte activation and in contributing to "Dw specificities".
Bach FH; Reinsmoen NL
Hum Immunol; 1986 Jul; 16(3):271-5. PubMed ID: 2424876
[No Abstract] [Full Text] [Related]
23. Inhibition of the alloimmune response with synthetic nonpolymorphic class II MHC peptides.
Murphy B; Akalin E; Watschinger B; Carpenter CB; Sayegh MH
Transplant Proc; 1995 Feb; 27(1):409-10. PubMed ID: 7879041
[No Abstract] [Full Text] [Related]
24. Ia-like antigens on human T lymphocytes: relationship to other surface markers, role in mixed lymphocyte reactions, and structural profile.
Indiveri F; Wilson BS; Russo C; Quaranta V; Pellegrino MA; Ferrone S
J Immunol; 1980 Dec; 125(6):2673-8. PubMed ID: 6448901
[No Abstract] [Full Text] [Related]
25. Allostimulating cells in man. Quantitative variation in the expression of HLA-DR and HLA-DQ molecules influences T-cell activation.
Nuñez G; Ball EJ; Myers LK; Stastny P
Immunogenetics; 1985; 22(1):85-91. PubMed ID: 3160658
[No Abstract] [Full Text] [Related]
26. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
27. Xenogeneic T-cell-mediated immune reactivity in the model of pig-to-humans: first findings with native stimulator cells.
Ulrichs K; Eckstein V; Müller-Ruchholtz W
Transplant Proc; 1994 Apr; 26(2):1045-6. PubMed ID: 8171462
[No Abstract] [Full Text] [Related]
28. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
29. Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells.
Socarras S; Matriano J; Streilein JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):354-6. PubMed ID: 8438332
[No Abstract] [Full Text] [Related]
30. Autologous mixed lymphocyte reaction in man. V. Functionally and phenotypically distinct human T-cell subpopulations respond to non-T and activated T cells in AMLR.
Damle NK; Gupta S
Scand J Immunol; 1982 Jul; 16(1):59-68. PubMed ID: 6214846
[No Abstract] [Full Text] [Related]
31. [A change in the expression of histocompatibility antigens could lead to autoimmunity].
Pujol-Borrell R; Bottazzo GF; Feldmann M
Med Clin (Barc); 1984 Apr; 82(13):594-5. PubMed ID: 6610082
[No Abstract] [Full Text] [Related]
32. The reduced expression of HLA-class II antigens and adhesion molecules on monocyte surface after phagocytosis of bacteria.
Baran J; Pryjma J
Arch Immunol Ther Exp (Warsz); 1994; 42(2):101-6. PubMed ID: 7503642
[TBL] [Abstract][Full Text] [Related]
33. Non-T cell disturbance causes the suppression of the autologous mixed lymphocyte reaction in patients with gastric carcinoma.
Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Noguchi K; Mizobata S; Tamai M; Hotta T; Arii K
Anticancer Res; 1995; 15(3):799-804. PubMed ID: 7645961
[TBL] [Abstract][Full Text] [Related]
34. Ia antigen-stimulated proliferation and IL-2 production in the syngeneic mixed lymphocyte reaction.
Lattime EC; Golub SH; Gillis S; Pecoraro GA; Stutman O
Transplant Proc; 1981 Mar; 13(1 Pt 2):1055-6. PubMed ID: 6455814
[No Abstract] [Full Text] [Related]
35. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
Palacios R
J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
[TBL] [Abstract][Full Text] [Related]
36. Absence of demonstrable suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of DR-positive maternal T cells.
Pollack MS; Kapoor N; Sorell M; Morishima Y; Dupont B; O'Reilly RJ
Transplant Proc; 1981 Mar; 13(1 Pt 1):270-2. PubMed ID: 6455792
[No Abstract] [Full Text] [Related]
37. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
[TBL] [Abstract][Full Text] [Related]
38. The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction.
Palacios R; Claesson L; Möller G; Peterson PA; Möller E
Immunogenetics; 1982; 15(4):341-56. PubMed ID: 6210631
[No Abstract] [Full Text] [Related]
39. Immunology of graft rejection.
Lafferty KJ; Simeonovic CJ
Transplant Proc; 1984 Aug; 16(4):927-30. PubMed ID: 6611619
[No Abstract] [Full Text] [Related]
40. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
